Initially, the patient L4 TB specimen at diagnosis was classified as MET-amplified adenocarcinoma, and additional analysis showed positive neuroendocrine staining in a few tumor cells, in addition to SLFN11+ cells. This evidence concerns the gene SLFN11 and adenocarcinoma.